EUVIMEDEUVIMED entdecken
Crossref

Targeting Cancer Cells With Triazene‐Appended Morpholine Chalcones: Antiproliferative Activity and ROS‐Dependent Apoptotic Mechanisms

Ahammed Ameen Thottasseri iD, Sathyapriya Chandramohan, Rajesh Ravichandran, Deepthi Ramesh iD, Anju Agnes Tom iD, Rukkumani Rajagopalan, Tharanikkarasu Kannan iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Ahammed Ameen Thottasseri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pondicherry University, Puducherry, India. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Apoptosis, Chalcones, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is an extremely diverse and unpredictable disease on multiple levels. To find novel compounds with anticancer therapeutic potential, we designed and synthesised a library of triazene‐appended morpholine chalcones and screened their activity against breast, lung and colorectal cancer cell lines. ( E )‐1‐{4‐[( E )‐morpholinodiazenyl]phenyl}‐3‐(3,4,5‐trimethoxyphenyl)prop‐2‐en‐1‐one (Compound 22 ) displayed notable cytotoxicity against human breast cancer cells (MDA‐MB‐231) and colon cancer cells (SW480), with IC 50 values of 20 and 12.5 µM, respectively. Interestingly, when tested on non‐cancerous HEK‐293T cell lines, Compound 22 exhibited minimal or no cytotoxic effects, indicating its safety towards non‐transformed cells. Furthermore, Rhodamine 123 and 2′,7′‐dichlorodihydrofluorescein diacetate (DCFH‐DA) staining assays revealed that Compound 22 induces apoptosis through the intrinsic pathway involving mitochondria and reactive oxygen species (ROS) generation, as supported by other staining assays. The compound also arrests the cell cycle at the G1 phase and inhibits cell migration and invasion. Taken together, this study reports that Compound 22 exhibits antiproliferative, apoptotic and anti‐metastatic effects against breast and colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesApoptosisChalconesAntineoplastic AgentsMorpholinesHumansCell ProliferationDrug Screening Assays, AntitumorStructure-Activity RelationshipCell Line, TumorMolecular StructureDose-Response Relationship, DrugCell Movement

Stichwörter der Autor:innen

breast cancerchalconecolon cancermolecular hybridisationtriazene

Substanzen

Reactive Oxygen SpeciesChalconesAntineoplastic AgentsMorpholinesmorpholine

Autor:innen und Institutionen

  • Department of Chemistry, Pondicherry University, Puducherry, India.
  • Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry, India.

ORCID-Profile: Ahammed Ameen Thottasseri, Deepthi Ramesh, Anju Agnes Tom, Tharanikkarasu Kannan

Zitieren

APA

Thottasseri, A. A., Chandramohan, S., Ravichandran, R., Ramesh, D., Tom, A. A., Rajagopalan, R., & Kannan, T. (2025). Targeting Cancer Cells With Triazene‐Appended Morpholine Chalcones: Antiproliferative Activity and ROS‐Dependent Apoptotic Mechanisms. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500200

Vancouver

Thottasseri AA, Chandramohan S, Ravichandran R, Ramesh D, Tom AA, Rajagopalan R, et al. Targeting Cancer Cells With Triazene‐Appended Morpholine Chalcones: Antiproliferative Activity and ROS‐Dependent Apoptotic Mechanisms. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500200

BibTeX
@article{Thottasseri2025,
  author = {Thottasseri, Ahammed Ameen and Chandramohan, Sathyapriya and Ravichandran, Rajesh and Ramesh, Deepthi and Tom, Anju Agnes and Rajagopalan, Rukkumani and Kannan, Tharanikkarasu},
  title = {Targeting Cancer Cells With Triazene‐Appended Morpholine Chalcones: Antiproliferative Activity and ROS‐Dependent Apoptotic Mechanisms},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500200}
}
Kostenlos starten →